Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Nov 19, 2021 10:07am
165 Views
Post# 34145225

RE:hyping TH

RE:hyping THNo false hope given by Levesque and Beliveau, but a huge false hope given by the host Pierre-Olivier Zappa. TH1902 will not be a cure for cancer. Maybe in the future, in favorable cases some patients will be cured, but that already exist. Also, maybe in the future TH19P01 with another cytotoxic agent, better than docetaxel could be more poweful, but we are far from that right now. Also, you cannot talk of cancer and a cure for it as if cancer was a single illness. Cancers are a family of different diseases with a single trait, genetic deregulation of cell propagation. But this deregulation is caused by many different mutations. So impossible to treat or even cure cancer with a single approach. So to talk about a cure for cancer was pure bullsh*t on the part of the host. Sensationalism at its best, but hey, some wants promotion, there you have it!

princess77 wrote: Finally TH being talked up by the company, I appreciate it. I don't see any false hope being given in that article. They are excited, finally.



<< Previous
Bullboard Posts
Next >>